As somatic cells in the testis seminiferous tubule, Sertoli cells provide the medium for spermatogenesis. One of the important functions of Sertoli cells is synthesizing and secreting cell factors to affect the production of sperm; however, much of those molecular regulation mechanisms remain unknown. Here, we confirm the localization of protein SPATA2 (spermatogenesis-associated protein 2), which had previously been shown to be highly expressed in Sertoli cells of the adult mouse testis. To further conduct a functional study, we generated SPATA2 global knockout mice via use of the CRISPR/Cas9n gene editing technology. The 120-day-old knockout mice testes showed almost a 40% decrease in size and weight and variations in the histomorphology of the seminiferous epithelium, with a 40% decrease in sperm count. Further examination revealed that the proliferation of germ cells in the seminiferous tubules was attenuated by 28%. In addition, we found that SPATA2 deletion led to an approximately 70% increase in the inhibin alpha-subunit mRNA and protein level in the testes compared to that of wild-type mice. Our data revealed the impact of SPATA2 on male fertility and suggested that SPATA2 ensures the normal secretory function of Sertoli cells.
Introduction
The rodent seminiferous epithelium in the testis is a highly organized unit in which spermatogenesis occurs. Sertoli cells (SCs) are known as the "medium cells" stretching from the bottom layer to the lumen of the seminiferous epithelium [1] . Their main function is nourishing germ cells and playing an important role in the formation of the blood-testis barrier, which offers a stable and independent microenvironment for spermatogenesis and protects haploid germ cells from the immune system [2] [3] [4] . Another important role of SCs is in its secretion of multiple kinds of cell factors and proteins, including androgen binding protein (ABP), anti-Mullerian hormone (AMH), FSH receptor (FSHR), androgen receptor (AR), SOX9, activin, inhibin, P450, etc. [5, 6] . Among these proteins, inhibin and activin, belonging to the TGF-β superfamily of proteins, play a key role in regulating the synthesis and secretion of pituitary FSH, which mainly acts on SCs to promote the production and maturation of spermatozoa [7, 8] . Inhibin is a heterodimer of an inhibin α-subunit and an inhibin β-subunit, whereas activin is a dimer of two β-subunits, while the β-subunit has two kinds of isoforms (βA and βB) [9] . In the male reproduction system, inhibin α-subunit mRNA is primarily expressed in SCs of the testis [10] [11] [12] . Inhibin performs its function to inhibit FSH secretion, which is contrary to the function of activin [8, 9] . The serum inhibin content in females presents cyclic variation, but it remains at a low level in males. Even so, inhibindeficient mice, induced by disruption of the inhibin α-subunit gene, have been reported to develop ovarian and testicular stromal tumors and die at 3-4 months old [13, 14] . In addition, inhibin α-subunit overexpression mice exhibit impaired fertility and an approximately 50% reduction in sperm numbers, along with decreased FSH levels [10] . The transcription of inhibin-α may be regulated by several transcriptional factors due to the presence of a cAMP response element (CRE), SF-1 binding site, and other transcriptional factor binding sites on the inhibin-α promoter [15] .
Here, we investigate a testis SC protein named SPATA2 (spermatogenesis-associated protein 2), which is also called PD1, that has been shown to be expressed in SCs of the human testis [16, 17] . Several years ago, Spata2 was shown to be more highly expressed in the testis than other tissues and localized in the SC cytoplasm in humans and rats [16, 18, 19] . Its gene expression increases with age until adulthood and has been proven to be able to be upregulated after FSH stimulation in vitro [20] . A reduction in the Spata2 gene expression level has been associated with several infertility symptoms, which suggests that the SPATA2 protein may play a role in maintaining normal reproduction ability [16, 18, 21] . In addition, its expression pattern shows a correlation with that of inhibin B, indicating that the SPATA2 protein may be involved in the feedback regulation of FSH secretion [19] .
A series of recently published reports have demonstrated that the SPATA2 protein serves as a direct binding intermediate that bridges HOIP, the catalytically active component of the linear ubiquitin chain assembly complex (LUBAC), and the deubiquitinase cylindromatosis (CYLD), thereby recruiting CYLD to tumor necrosis factor receptor 1 (TNFR1) signaling complexes [22] . In detail, SPATA2 interacts with CYLD through its PUB domain close to the N-terminal and directly contacts HOIP via a PIM close to the C-terminal [23, 24] . In addition, SPATA2 has been proposed to be responsible for suppressing the ubiquitination of LUBAC substrates Lys63-Ub, Met1-Ub, etc. [23] , thereby negatively affecting TNF-induced NF-κB and MAPK signaling [24, 25] . SPATA2 has been speculated to play a role in suppressing cytokine secretion by SCs, and Spata2 deficiency in mice could impact male fertility [26] . However, its exact function in male reproduction and the characteristics of the knockout (KO) mouse remain unclear.
In this study, we aimed to confirm the localization of the SPATA2 protein in the mouse testis and investigate its physiological function in male mice. Therefore, we generated a Spata2-deficient mouse using the CRISPR/Cas9n gene editing system with the Cas9 double-nicking nuclease and demonstrated that the Spata2 KO mice presented a reduced testis size and sperm number relative to that of wild-type (WT) mice. Reductions in cell proliferation and germ cell number were observed in the Spata2 -/-gonads. Further examination revealed that the inhibin α-subunit had an augmented expression in the Spata2-deficient testes. Briefly, our results suggested that SPATA2 maintains the male mouse reproduction ability at a normal level.
Materials and methods

Animals and tissue collection
All of the mice used for this study were raised in an animal feeding room with controlled temperature (22
• C) and humidity (60%-70%) and a 12-h light, 12-h dark cycle. All the animal experimental procedures were allowed by the Chinese Association for Laboratory Animal Sciences. Sufficient mouse or rat fodder and tap water were available for mice throughout the experiment. The ICR mice (outbred mice delivered from the Institute of Cancer Research) used in this study were purchased from the Animal Institute of the Chinese Medical Academy (Beijing, China), except for the Spata2 -/-mice, which were generated by our laboratory. The animal tissue was washed in PBS and then fixed in 4% PFA for 4 h at room temperature (RT) for tissue sectioning or flash-frozen in liquid nitrogen for mRNA and protein extraction.
RNA extraction and real-time quantitative PCR
Trizol reagent (Vigorous Biotechnology) was used to isolate the total RNA from the tissue, including RNA from the mouse testis, spleen, epididymis, ovary, kidney, liver, heart, lung, brain, etc. In addition, DNase I was used to remove the genomic DNA. Here, 1.5 μg RNA was reverse transcribed into DNA with M-MLV reverse transcription reagents (Promega) in a 25-μL reaction system. Real-time quantitative PCR was performed in a total volume of 15 μL of reaction mixture containing 50 ng of cDNA samples using the SYBR Green Real-time PCR Master Mix Kit (Takara) on the ABI 7500 Real-time PCR System (Applied Biosystems, Foster City, CA, USA). Each sample was processed in triplicate through the PCR procedure: 95
• C for 2 min, followed by 40 cycles of 95
• C for 15 s and 60
• C for 1 min. The results were calculated based on the Ct method using GAPDH as the endogenous control. The primers are listed in Supplemental Table S1 . The primer specificity was ensured by the unique PCR product bands in agarose gel electrophoresis and a single peak in the dissociation curve in real-time PCR.
Western blot
The frozen tissue samples were ground and lysed in RIPA lysis buffer; then, the protein concentration was determined by using the BCA assay reagent. Each well of 12% SDS-polyacrylamide gels was loaded with 50 μg of protein for electrophoresing, and then, the protein was transferred onto PVDF membranes. The membranes were blocked with 5% (w/v) nonfat dry milk for 3 h at RT and incubated with rabbit IgG anti-SPATA2 (dilution 1:1000), mouse IgG anti-GAPDH (dilution 1:5000), and other primary antibodies, including inhibin α-subunit and inhibin βA-subunit listed in Table 1 , overnight at 4
• C.
After washing three times in TBST (0.1% Tween-20 in TBS), the membranes were incubated for 2 h at RT with HRP-conjugated goat anti-rabbit IgG (GAR-HRP, dilution 1:10000) or HRP-conjugated goat anti-mouse IgG (GAM-HRP, dilution 1:10000). Then, after washing the membranes for 30 min with three changes of TBST, the ECL reagent kit was used to detect the band intensity. The results were assessed by using the ImageJ software, and GAPDH was used as the endogenous control. The information of the primary antibodies is listed in Table 1 .
Hematoxylin and eosin staining
The fixed tissue was placed into 70% ethanol and dehydrated in increasing concentrations of ethanol, followed by treatment with xylene. Finally, the tissue samples were embedded in paraffin and cut into 5-μm thick paraffin sections. The sections for H&E staining were dewaxed, rehydrated, and stained with hematoxylin and eosin before dehydration and finally imaged for histological examination.
Immunohistochemistry
The 5-μm paraffin sections were dewaxed and rehydrated, and then, antigen retrieval was performed by microwaving the sections in boiling 0.01 M sodium citrate buffer (pH 6.0). Figure S1 ).
Immunofluorescence
The fixed tissue was soaked in 30% sucrose for 2 h, followed by embedding into Tissue Tek O.C.T. compound (TaKaRa Biotechnology, Dalian, China). The frozen tissue was cut into 10-μm thick cryosections. Antigen retrieval was performed on the sections as described above. Then, sections were blocked with 10% normal goat serum in PBS for 1 h at RT and incubated with rabbit anti-SPATA2 IgG (dilution 1:50) or other primary antibodies listed in 
Spata2-deficient mice generation
We generated Spata2-deficient mice by using the CRISPR/Cas9n gene editing system, which has been proven to be more precise resulting in fewer off-target effects relative to that observed with the CRISPR/Cas9 system because the Cas9n nuclease leads to doublestranded breaks through recognizing a pair of targets set on different DNA strands rather than relying on a single target, thereby extending the specific recognition sequence from 20 to 40 bp [27] . The strategy that we used included injecting the Cas9n nuclease mRNA and single-guide RNA into one-cell embryos. The first step was constructing the plasmid that was used for transcribing the RNA in vitro. A backbone plasmid (named the T3-sgRNA vector in supplemental data) with a T3 promoter, to which an sgRNA coding sequence without a target sequence was added, had been cut into a linear vector by endonuclease type II BbsI. Then, we set two pairs of targets for Cas9n: one pair at exon 2 of the Spata2 gene and another pair at exon 3. The target sequences are in Supplemental Table S2 and were designed by using an online CRISPR design tool (http://crispr.mit.edu). These target sequences were added with cohesive-end ligation when they were synthesized and connected to the linear vector described above.
Another vector (named T3-Cas9n in supplemental data) with a T3 promoter that carried Cas9n nuclease cDNA was used for transcribing Cas9n nuclease mRNA. Both vectors T3-sgRNA and T3-Cas9n could be used for mRNA transcription in vitro with the mMESSAGE mMACHINE Kit (Ambion). The RNA was purified, and a polyA tail was added to the Cas9n RNA. The 40-day-old ICR female mice were injected with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG) and then housed with ICR adult male mice in the same cage. The next morning, the plugged female mice were euthanized, and the zygotes in the oviduct were removed 20 h after the time of the hCG injection. The Eppendorf microinjection system was used to inject the RNA into the zygotes. The embryos were cultured in 5% CO 2 , 37
• C incubators for 24 h and put into the oviduct of pseudopregnant female mice. After the transplanted embryos were born, PCR was used to determine whether they had a mutant in Spata2 gene. The primers are in Table 2 . If the length of the PCR product (amplified by the outer primers in Table 2 ) was less than 1400 bp, it was sequenced by a sequencing company. Then, we chose a proper mutant individual to establish a mutant genetic line.
Mouse breeding and genotyping
The generated Spata2 mutant mouse was crossed with WT ICR female mice, and the next generation mice were crossed with each Table 2 . Primers used for mouse genotyping.
Primer name
Forward primer (5'-3') Reverse primer (5'-3')
Outer primers TTCATGTGATGTGCCAGCCT GCAGACTCAGTGAGGCCTTT Inner primers GGACCAGAGTCCCAGTTGA AAGCCCCAGGATGTCCATTTT
The outer primer forward sequence located in exon 2, while reverse primer located in exon 3. The gap between them is more than 1400 bp. Since the PCR program had a process of extending at 72
• C for 30 min, we cannot get a PCR product from WT ones, but a 458-bp PCR product from the KO and heterozygous ones. The inner primers were set in the deletion region, so there was no PCR products from the KO mice samples. Thus, we can distinguish the KO ones from the heterozygous.
other. The genotyping of their offspring was performed by the method described above. Genomic DNA was isolated from tail biopsies, and the primers used for the genotyping PCR are listed in Table 2 . The results were visualized on a 2% agarose gel with ethidium bromide.
Sperm volume analyses via flow cytometer
The cauda epididymis was punctured by a needle, and sperm was released directly into a 1-ml 0.9% NaCl solution at 37
• C. After a 15-min incubation, the cell nuclei of every sample were stained with PI before using a 20-μL sperm suspension to investigate via a flow cytometer (Becton Dickinson, San Jose, CA, USA). After monitoring the cell count of a certain volume, the data were then exported by the Flowjo5.7.2 software for image presentation and statistics.
Sperm motility analyses
For the mouse sperm motility analyses, sperm were released from the cauda epididymides into prewarmed (37 • C) sperm capacitation medium by puncturing using a needle. Fifteen minutes later, the computer-assisted semen assay (CASA) system (Version 12 CEROS, Hamilton Thorne Research) was used with the following settings: for cell detection: minimal contrast, 50; minimal cell size, 4 pixels; and 60 frames were acquired at a frame rate of 60 Hz. At least 200 tracks were measured for each sample at 37
• C with a Slide Warmer (#720230, Hamilton Thorne Research) [28] .
In vivo fertilization analyses
For the in vivo fertilization assay, two types of females were involved: gonadotropin-induced superovulation female mice and normal female mice. They were mated with Spata2 KO male mice and WT male mice. The plugged females were sacrificed at 15:00-16:00 2 days post coitus (dpc), and the oviducts were flushed to count the number of two-cell embryos to obtain the fertilization rate.
Fertility test
Four-month-old males of three genotypes participated in the breeding assay. Each male mouse was caged with two WT ICR female mice (7-8 weeks old). The vaginal plug was checked the next morning. As soon as a vaginal plug was identified, the male was allowed to rest for 2 days. After that, the other two females were placed in the cage for another round of mating. The plugged female was separated in a cage to live alone until the delivery, when the pregnancy results were recorded. If a female generated no pups by 22 dpc, it was deemed as not pregnant. Each male mouse underwent four cycles of the above breeding assay [28] .
Leydig cell isolation
The testis albuginea was removed from 90 day post parturition (dpp) testes without destroying the internal tissue. Then, the internal tissue was washed three times with PBS solution supplemented with 100 UI/ml streptomycin and penicillin and then digested in DMEM (Dulbecco Modified Eagle Medium, Life Technologies, Inc.-Invitrogen) with 1 mg/ml collagenase II (Life technologies, Inc.-Gibco) for 30 min with five inversions every 5 min without destroying the integrity of the seminiferous tubules. The supernatant containing Leydig cells was centrifuged at 500 × g for 10 min. The collected cells in the precipitate were Leydig cells and were treated with Trizol for RNA isolation [29] .
Statistical analysis
All the experiments were repeated at least three times. Every assay was performed by using at least three mice per experiment group. All data were analyzed using one-way factorial analysis of variance, followed by Student t-test. All values are expressed as means ± SEM. A value of P < 0.05 was considered to be significant and marked with a " * ."
Results
Spata2 expression in mouse testes
First, we detected Spata2 mRNA and protein levels in different tissues by using real-time PCR and western blotting, and the results showed that both Spata2 mRNA and protein levels in the testes were especially higher than in the other tissues of adult mice (Figure 1A-C) . Furthermore, we examined the Spata2 mRNA expression from the first day after birth (1 dpp) to 90 dpp and the protein levels from 14 dpp to 120 dpp, and the results showed that the Spata2 expression level remained at a lower level during development but became increasingly higher after 45 dpp ( Figure 1D-F) . Leydig cells separated from mature male testes had a low Spata2 mRNA expression level, which was in sharp contrast to the levels in the testes at 90 dpp ( Figure 1D ). In addition, we performed immunofluorescence experiments to identify the cell type expressing SPATA2 and found that SPATA2 was specifically located in the cytoplasm of the SCs (Figure 2A ). The immunohistochemistry assay also confirmed that the protein was expressed in SCs from stage I to stage XII of the testis seminiferous epithelium [30] (Figure 2B ). These data indicated that SPATA2 may be involved in some functions of the SCs in the adult mouse testis. The negative controls were added in the supplementary data which were conducted by using rabbit IgG (Supplemental Figure S1 ).
Generation of an Spata2 global knockout mouse via genomic editing technology mediated by the RNA-guide CRISPR/Cas9n system To identify the function of SPATA2 in SCs, we generated Spata2 KO mice using the CRISPR/Cas9 double-nicking nuclease gene editing technology. Two pairs of Cas9n targets were set in exon 2 and * means significant difference group, P < 0.05. GAPDH was used as a loading control. dpp, days post parturition.
exon 3 [27, 31] ( Figure 3A ). The nicking sites were always placed between the two PAMs of each pair of targets [27] ; then, three mouse lines were generated. They were respectively deleted 13 bp, 801 bp, and 1009 bp. Considering the deleted segment of the 801-bp deleted line was located in the last exon and the deleted segment of the 13-bp deleted line was too short, the mice with 1009 bp deletion on the genome DNA were used to investigate the gene's function (Figure 3B ). The deletion area was from the 83 bp behind the initiation codon ATG on exon 2 to the 199th base of exon 3, including intron 2 ( Figure 3B ). Therefore, we thought this to be an effective mutant and built a mutant mouse genetic line with Spata2 deficiency. The F0 generation was bred for two generations to generate a homozygote according to the Mendel law of inheritance. Through the breeding strategy and genotyping method described above, we generated and distinguished the KO mouse ( Figure 3C ). The KO efficiency was assayed by RT-PCR, western blot, and immunofluorescence (Figure 3D-F) . The results indicated that the Spata2 gene was destroyed in the KO animals, and both its mRNA and protein were eliminated in the testes.
Spata2 -/-males showed an impaired reproduction system
Because of the expression patterns of Spata2 in the mouse testes, we examined the reproduction phenotype of Spata2 -/-mice at the age of 45 days old and 120 days old. As the images show, the 120-dpp testis size was reduced but there was not much of a difference in the appearance of the epididymis ( Figure 4A and B). In addition, the testis weight detected at 120 days after birth was significantly decreased in Spata2 KO mice, from 0.127 g on average in the WT controls to 0.081 g on average in the KO mice, while the 45-day-old male mice did not show this obvious variation ( Figure 4C ). There was no change in the body size or weight at either age ( Figure 4D) . Therefore, the testis ratio in the 120-dpp KO mice was also significantly lower than that of the controls, at 0.24% compared to 0.36% ( Figure 4E ). Histological analyses showed that there was no obvious difference between WT and KO mice when the mice were 45 days old ( Figure 4F-H) . However, in 120-day-old KO mice, the seminiferous epithelium was thinner, at 42% relative to that of WT controls, and the diameter of the seminiferous tubules was reduced to 19% relative to that of WT controls ( Figure 4I -K).
As described above, the difference between KO and WT mice was more significant at 120 days after birth; therefore, the sperm volume was analyzed in 120-day-old mice. A sparse sperm collection in the lumen of the Spata2 -/-mouse cauda and caput epididymis was shown in the histological staining ( Figure 5A and B) , and the sperm number in the epididymis was reduced by 40% compared to that of controls ( Figure 5C ). Furthermore, we performed flow cytometry-based cell counting and found that the result was consistent with that of the sperm count assay ( Figure 5D and E). The forward and side scatter gates graph of flow cytometry was showed in supplemental data and indicated that the samples from KO mice contained less sperm (Supplemental Figure S2) . The CASA revealed that the sperm total motility was marginally but not significantly lower and the progressive motility had been weakened by almost 50% in KO mice compared to WT mice ( Figure 5F ). The velocity of the KO sperm was also lower than that of the WT sperm, especially the curvilinear velocity (VCL), which displayed a 20% reduction ( Figure 5G ). However, there was no evident difference in the motion morphology, including the lateral amplitude (ALH) or beat cross frequency (BCF) ( Figure 5H ). All the data presented in Figures 4 and 5 were derived from the experiments performed on the mice line with 1009 bp deletion. It is well to be reminded that we also detected the indexes of the line with 13 bp deletion and found that they showed same phenotypes as 1009-bp deleted mice. The seminiferous tubules displayed the thin epithelium as well as 1009-bp deleted line (Supplemental Figure S3) . The following experiments were also performed by using the line with 1009 bp deletion.
Breeding and fertilization assays
Furthermore, we performed a breeding assay and in vivo fertilization analyses. In the breeding assay, each 4-month-old male mouse was allowed to mate with four WT females. After one time of successful mating (indicated by a vaginal plug), the plugged female was tracked for pregnancy results, including the litter size. We found that although the Spata2 -/-males could mate normally with the females, the pregnancy rate of the females that had mated with KO mice was reduced by approximately 10% relative to those that had mated with heterozygotes. The litter size of the KO males was reduced by approximately 2 pups on average, which was a significant difference (Table 3) . To further examine the reproduction ability of the Spata2 KO mice, we performed an in vivo fertilization assay with the KO and WT mice. In the analysis with normal female mice, there was no significant difference between the sperm of both genotypes (Supplemental Figure S4A-C) . On the other hand, when tested with superovulated females injected with PMSG and hCG, a significant decrease in the fertilization rate from 97.5% to 57.1% was revealed (Supplemental Figure S4D-F) , which was indicated by calculating the number of two-cell embryos retrieved from the female oviduct on the second day after mating. These results suggested that SPATA2 deletion resulted in a decline in male reproductive ability.
Attenuated cell proliferation and reduced germ cell quantity in the KO mice testis, but without a decrease in the quantity of Sertoli cell
We performed immunofluorescence staining of PCNA and cleaved caspase 3 and showed that the PCNA-positive signal was much higher in the WT testis than in the Spata2-deficient testis ( Figure 6A ). Some tubules of the KO testis had no positive cells, while almost every tubule in the WT testis had a positive signal. To quantify this difference, we counted the percentage of tubules with a PCNA-positive signal. The results showed a statistically significant difference with 97% positive tubules in the WT testis and 71% in the KO testis (Figure 6B) . The cleaved caspase 3 signal was very low in both the WT and KO testis ( Figure 6C ) and did not show a quantifiable difference ( Figure 6D ).
Considering the variation in morphology of seminiferous tubules and germ cell proliferation, we tended to further assess the amount of germ cells and SCs. Then the immunofluorescence staining of TRA98 (T-cell receptor alpha chain) and Wt1 (Wilms tumor 1) in 120-dpp mice testis showed the germ cell and the SC nucleus ( Figure 7A and C). Furthermore, we counted the population of germ cells and SCs. The statistical analyzation indicated that the number of SCs in the KO mice did not differ from the WT mice, but the germ cells reduced due to Spata2 KO ( Figure 7B and D) . In addition, the puberty mice testis (testis of 7 dpp, 14 dpp, 21 dpp, 28 dpp) were also observed the SCs number through Wt1 positive signal (Supplemental Figure  S5) . But there is no difference between WT and KO during puberty. These results suggested that SPATA2 could not have a function in SCs proliferation and differentiation at an early stage of development and had no influence on the SC population at adult age but disturbed the functional maturation of SCs after sex maturation, leading to an influence on spermatogenesis. Four-month-old males with different Spata2 genotypes were used, each for mating until that each male plugged four WT females. The plug rate is the number of plugged females dividing the mating times of one male mouse. Plugged female was caged alone, then pregnancy rate was calculated as the ratio of the number of females with pregnancy to the plugged females. When calculating average litter size, only the females that generated pups were included. The litter size of KO males was reduced, and the difference between KO and WT mice was significant. * P < 0.05. Reduced quantities of differentiating spermatogonia and spermatocyte in Spata2 KO mice
Due to the lower proliferation rate of germ cells in the Spata2 -/-testis, the number of spermatogonia and spermatocytes was also decreased in the seminiferous tubules, indicated by the PLZF (promyelocytic leukaemia zinc finger), γ H2AX (gamma histone variant H2AX), and SCP3 (synaptonemal complex protein 3) protein localization in the testis [3, [32] [33] [34] . There was a reduction in the number of spermatogonia marked by PLZF in the Spata2 KO mouse testis ( Figure 8A ), but the statistical analysis did not show a significant difference because the P value was not less than 0.05 ( Figure 8D ). The γ H2AX-positive cells, which represent the spermatocytes from leptotene to pachytene [35] , reduced in Spata2 -/-testis comparing to the WTs, and the difference between them was significant ( Figure 8B and E). The SCP3 immunofluorescence in the testis of two genotypes was performed to mark the germ cells during meiosis and indicated that the Spata2 KO testis had fewer spermatocytes than the WT testis ( Figure 8C ). Then, we performed the quantification of positive cells in each seminiferous tubule cross section of the different seminiferous stages, including stage I-VI, stage VII-VIII, stage IX-X, and stage XI-XII. There were significant differences between the WT and KO testis in all of these stages. The was an 11% reduction in stage I-VI, 26% in stage VII-VIII, 49% in stage IX-X, and 30% in stage XI-XII tubules ( Figure 8F ).
Deletion of Spata2 resulted in an increase in the inhibin α-subunit
To investigate the impact of Spata2 KO, we detected the mRNA levels of ABP, AR, FSHR, inhibin α-subunit, inhibin β-subunit A, inhibin β-subunit B, Sox9, Gdnf, and AMH in 120-dpp KO/WT adult testes, due to their critical role in the regulation of SC function [4, 5, 36] . The real-time PCR analysis showed that the inhibin α-subunit in the KO testis was increased by approximately 70%, while other genes only exhibited a subtle variation ( Figure 9A ). The inhibin α-subunit is only a component of inhibin, not activin, and its expression is usually at a low level in adult males. Therefore, the main function of inhibin A, which is composed of one α-subunit and one β-subunit A, has always been thought to be the regulation of FSH secretion [10] . Therefore, a western blot assay was performed to detect the protein level of the α-subunit and β-subunit A. The results showed that the protein levels were consistent with the mRNA levels. The relative expression of the inhibin-α protein was increased in the KO mice testis, but there was little difference in the expression of the inhibin-βA protein ( Figure 9B-D) . Therefore, we assumed that Spata2 -/-testes exhibited an increase in the expression of inhibin, potentially resulting in endocrine abnormalities. Further investigation revealed that the level of p-ERK in KO testis was higher than in the WT testis ( Figure 9E ), which was considered the reason of increasing inhibin-α. And the gray scanning analysis showed that the p-ERK level relative to ERK level in KO testis was increased by 23% ( Figure 9F ). Because inhibin negatively regulates FSH, the mRNA levels of Cga (α-subunit of gonadotropin) and FSH β-subunit were detected and were both decreased in KO mice pituitary ( Figure 9G ). The western blot assay showed that the protein levels of Cga and LH β-subunit did not have a significant change while the FSH β-subunit decreased almost one half in KO mice pituitary ( Figure 9H-K) .
Discussion
This study first confirmed that the Spata2 gene was highly expressed in the adult mouse testis, while the other mouse tissues and the childhood mouse testis maintained a low expression level. These results were similar to previous reports on Spata2 expression in the rat [19, 20] . In addition, we demonstrated that the SPATA2 protein was localized to the cytoplasm of the mouse SCs through immunofluorescence. Immunohistochemistry of SPATA2 in different spermatogenic epithelium stages also showed the irregular shape of SCs, which serves to nourish and structurally support the developing germ cells. The human ortholog gene of Spata2, previously named PD1, has also been proven to be localized to the cytoplasm of SCs [16, 19] .
The experimental results of the gene expression analysis suggested that this protein that is highly expressed in the adult testis might be involved in the regulation of SC status and spermatogenesis.
As the function of SCs is based on the specific shape and the tight junction between each other and the germ cells in the seminiferous epithelium [1, 37] , we determined that the functional research should be performed in vivo. Therefore, we decided to delete Spata2 in the mouse using the CRISPR/Cas9n genomic editing technology. We chose two pairs of appropriate targets to carry out DNA double-stranded breaks at two sites that were located in exon 2 and exon 3. So, a mouse with a fragment deletion was generated. Even though the mutant rate of embryos was lower when we injected the CRISPR/Cas9n system into zygotes rather than the CRISPR/Cas9, we still chose the double-nicking nuclease because this method is considered to be more specific for the target gene than Cas9 [27] . There are numerous reports illustrating the development of gene deficiency animal models via the CRISPR/Cas9 and CRISPR/Cas9n system and investigating the gene functions using these models [38] [39] [40] [41] . In addition, recent reports on the SPATA2 protein construction demonstrated that SPATA2 interacts with CYLD through its PUB domain. The conserved amino acids in the PUB domain are located at the 110th-120th amino acids of the protein, and mutation of this region will destroy the interaction of SPATA2 with CYLD [23] . Strikingly, the Spata2-deficient mouse we generated had a 1009-bp missing cDNA segment that corresponded to the 29th-172nd amino acids of the protein. In addition, the number of deleted bases was not divisible by 3, resulting in a frameshift mutation. The mutant sequence would make the Spata2 gene only be translated into 45 amino acids and then stopped by a termination codon. The PCR and western blot assays that we performed also demonstrated that Spata2 was effectively knocked out at both the genetic and protein levels. Therefore, this mouse model was considered able to be used to investigate SPATA2 function in vivo.
Considering the SPATA2 protein is mainly expressed in the sexual maturity phase, we investigated the phenotype of the reproductive system in Spata2 -/-adult mice. Even though the 45-day-old KO males did not have significant abnormalities in the gonads, the size and the weight of the testis were significantly decreased, and the volume of the sperm was reduced in the 120-day-old KO mice. In general, the decrease in the testis tissue size resulted in a reduction in germ cells and the production of fewer sperm, and these defects were aggravated along with increasing age. Further morphological and histological results showed that deletion of Spata2 led to diminution of the seminiferous tubule diameter and a thinner seminiferous epithelium in the older mice. However, no obvious change occurred during the developmental period in the testis (Supplemental Figure  S6) or the mature ovary (Supplemental Figure S7) . The reason for this lack of an effect could be due to the low expression of SPATA2 in these situations. The reduction in the sperm count could be proven by a sperm count analysis and the lower density of sperm in the Spata2 -/-epididymis tubule lumen. In addition, the KO mice also exhibited a higher rate of sperm aberration and restricted sperm vitality. However, the gene deficiency male mouse was not completely infertile.
The reasons for this were twofold. On the one hand, the deletion of SPATA2 did not cause complete failure of SC function, indicating that the physiological events participated by SPATA2 may compensate by other proteins. A recent report stated that SPATA2 interacts with CYLD and LUBAC to limit ubiquitination of LUBAC substrates. However, there are some other proteins, such as OTULIN, that can also participate in deubiquitination and further regulate the signaling pathway in which is SPATA2 [23] . These proteins may have partly compensated for the loss of SPATA2, so that only an attenuated reproductive phenotype was detected. On the other hand, the effect of Spata2 KO on the pregnancy rate and average litter size was not very pronounced despite a significant reduction in the sperm volume. We determined that is because the number of sperm that arrived and were coupled with oocytes was not reduced. There could be millions of sperm in once ejaculation of a normal mouse. Although the number of sperm decreased by approximately 50%, the sperm volume of an ejaculation could be more than a thousand. Given that the number of oocytes ovulated and the embryo implantation was limited, the KO mice would still have enough sperm to fertilize the female mice and produce offspring without much of a reduction in quantitative terms. In addition, the discrepancy between the two kinds of in vivo fertilization tests that was presented in the supplementary data also confirmed this conclusion. Under physiological conditions, the number of eggs that females ovulated was limited. Even though the overall sperm count was reduced, the number of sperm that arrived at the eggs was not changed by much. However, in the superovulated females, the difference became apparent. Previous studies have also provided some evidence that SPATA2 may play an essential role in humans. Severely oligozoospermic men have been shown to have an obviously lower expression of SPATA2 in the testes relative to men with normal spermatogenesis, and the SPATA2-positive signal in an azoospermic man, who presented a complete absence of germ cells in the testes, was further weakened. This information indicated that SPATA2 is closely related to spermatogenesis in humans and may be used as a marker of reproductive performance in clinical examination.
To investigate the mechanism of SPATA2 functioning in the testis, we assessed the relationship between Spata2 and the genes that are expressed and functional in SCs, including Sox9, AMH, Gdnf, inhibin-α, inhibin-βA, inhibin-βB, ABP, AR and FSHR. Interestingly, the expression of the inhibin α-subunit but not the β-subunit was dramatically upregulated in the Spata2 -/-testis. Because the only one function of inhibin α-subunit is constituting inhibin, a significant increase in inhibin α-subunit would cause a foreseeable increasing in inhibin.
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As the main function of inhibin is to negatively regulate FSH, we further speculated that FSH synthesis and secretion would tend to decrease with the deletion of Spata2. And we confirmed the decreasing expression of FSH in KO pituitary on both mRNA and protein levels. FSH has an important function in the regulation of spermatogenesis. It could facilitate the proliferation of spermatogonia and combine to the FSHR on the membrane of SCs, regulating cytokines expression in SCs. FSH has been known to promote the cAMP level in SCs through its membrane receptor FSHR and activate PKA signaling [42] . FSH and FSHR single mutant mice both showed a reduced sperm number and smaller testes but were still fertile [43, 44] . Mutations in FSHb or FSHR gene in men led to hypogonadism, azoospermia, and infertility [45] . And it had been proved that blocking endogenous FSH secretion in normal men could lead to significant decreasing in sperm volume and the phenomenon could be reversed by exogenous FSH [46] . Moreover, published results have also proven that overexpression of the inhibin α-subunit in rats leads to reproductive deficiencies, including smaller testes, reduced sperm number, and a decrease in FSH secretion [10] . The phenotypes of inhibin α-subunit overexpression rats were similar to those we observed in the Spata2 KO mice. Briefly, we conclude that losing SPATA2 resulted in upregulation of inhibin expression in the testes and downregulation of FSHβ expression in the pituitary.
In addition, our immunofluorescence results showed a weakened proliferation signal with PCNA in mature Spata2-deficient testes. The change in proliferation is probably due to the FSH decrease because FSH can facilitate spermatogenesis and the mitosis of spermatogonia. The KO mice testis would conduct slower mitosis cycles and produce fewer germ cells, as was shown with the TRA98, γ H2AX, and SCP3 immunostaining [6, 47] . The decrease in the number of PLZF-positive cells in KO mice testis was not significant. Given the PCNA-positive signal decreased in Spata2 KO testis, we speculated that both undifferentiated spermatogonia and differentiating spermatogonia decreased, and the differentiating spermatogonia would be reducing more because PLZF marked spermatogonial progenitor cells. In general, only if some aberrant events occurred in germ cells during fetal stages, the PLZF-positive cells would decrease. But the differentiating spermatogonia and spermatocyte would be easily decreasing if some defects emerged during postpartum testis development.
Considering SPATA2 protein's localization in SCs, we assessed the number of SC and found that it did not have a change. It was known that SCs would stop proliferation at puberty. We deemed there was no difference in the proliferation of SCs during puberty, because the SC number did not have a significant change in KO mice testis compared to the WT ones during 7 dpp-28 dpp. The histological staining of seminiferous tubules in 120 dpp testis showed that the diameter of seminiferous tubules and the thickness of seminiferous epithelium had reduced. So the path which germ cells from the basal SC into the adluminal compartment in the process of maturing would crossed through was shortened, and the total germ cells that the epithelium could contain would also be decreasing. This suggested SPATA2 has an influence on SC terminal differentiation and should be responsible for the reducing of germ cells in seminiferous epithelium.In recent studies, SPATA2 investigators who illuminated its molecular interaction questioned whether the Spata2 -/-mouse would also exhibit impaired male fertility at least partly similar to that seen in the CYLD -/-mouse, which shows a reduced testes size and impaired spermatogenesis [48] , and speculated that SPATA2 suppresses the cytokine production in SCs due to its negative regulatory relationship with NF-κB and MAPK [26] . In addition, we confirmed this view at the levels of the physiological phenomenon and gene function. Actually, SPATA2 has been demonstrated to mediate the recruitment of CYLD to the TNFR1 signaling complex [22, 23] and negatively regulate NF-κB and MAPK activation. In addition, deleting SPATA2 in an SC line, 15P-1 has been proven to enhance the phosphorylation of JNK, ERK, etc. [24] . In addition, there have also been previous reports that have proven that inhibin α-subunit expression could be enhanced through CREB activation induced by ERK1/2 phosphorylation [15, 49] . Therefore, we detected the level of ERK1/2 phosphorylation in testis and confirmed that KO of SPATA2 in vivo unduly activates the MAPK signaling pathway, leading to an increase in p-ERK, as well as transcription of inhibin-α. However, the exact mechanism still required further studies.
In conclusion, our results showed that Spata2 is highly expressed in the adult mouse testes and particularly in the SC cytoplasm. The Spata2-deficient mouse further revealed that SPATA2 plays an important role in testis function and is involved in the regulation of inhibin expression. Several groups of scientists who uncovered the novel cell signaling pathway in which SPATA2 is involved set the question regarding the role of SPATA2 in male reproduction. Our study supplied a new insight into the physiological function of SPATA2 in male gonads and indicated events in SCs in which SPATA2 may participate. These findings serve as a clue for further investigation into the functional mechanisms of SPATA2 in SCs. In addition, in light of the results we presented here and the previously published results on the weakened expression of Spata2 in those with dyszoospermia [16, 19] , reproductive impaired males could be speculated to show a decrease in the expression of SPATA2. Therefore, our study is also highly clinically relevant and indicates that this gene may serve as a marker of reproductive performance.
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